|
Name |
Ueckerchalasin E
|
| Molecular Formula | C30H39NO5 | |
| IUPAC Name* |
(16-benzyl-5,6-dihydroxy-5,7,13,14-tetramethyl-18-oxo-17-azatricyclo[9.7.0.01,15]octadeca-3,9,12-trien-2-yl)acetate
|
|
| SMILES |
CC(=O)OC1C=CC(C)(O)C(O)C(C)CC=CC2C=C(C)C(C)C3C(Cc4ccccc4)NC(=O)C213
|
|
| InChI |
InChI=1S/C30H39NO5/c1-18-10-9-13-23-16-19(2)20(3)26-24(17-22-11-7-6-8-12-22)31-28(34)30(23,26)25(36-21(4)32)14-15-29(5,35)27(18)33/h6-9,11-16,18,20,23-27,33,35H,10,17H2,1-5H3,(H,31,34)/b13-9+,15-14+/t18-,20+,23-,24-,25+,26-,27+,29-,30+/m0/s1
|
|
| InChIKey |
WNRLWCXSKKYWAW-CILUEWGHSA-N
|
|
| Synonyms |
NA
|
|
| CAS | NA | |
| PubChem CID | NA | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 493.64 | ALogp: | 3.7 |
| HBD: | 3 | HBA: | 5 |
| Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 95.9 | Aromatic Rings: | 4 |
| Heavy Atoms: | 36 | QED Weighted: | 0.428 |
| Caco-2 Permeability: | -4.842 | MDCK Permeability: | 0.00003330 |
| Pgp-inhibitor: | 0.694 | Pgp-substrate: | 0.101 |
| Human Intestinal Absorption (HIA): | 0.125 | 20% Bioavailability (F20%): | 0.014 |
| 30% Bioavailability (F30%): | 0.013 |
| Blood-Brain-Barrier Penetration (BBB): | 0.951 | Plasma Protein Binding (PPB): | 94.63% |
| Volume Distribution (VD): | 1.686 | Fu: | 5.63% |
| CYP1A2-inhibitor: | 0.024 | CYP1A2-substrate: | 0.118 |
| CYP2C19-inhibitor: | 0.142 | CYP2C19-substrate: | 0.633 |
| CYP2C9-inhibitor: | 0.176 | CYP2C9-substrate: | 0.118 |
| CYP2D6-inhibitor: | 0.098 | CYP2D6-substrate: | 0.155 |
| CYP3A4-inhibitor: | 0.904 | CYP3A4-substrate: | 0.558 |
| Clearance (CL): | 4.901 | Half-life (T1/2): | 0.047 |
| hERG Blockers: | 0.009 | Human Hepatotoxicity (H-HT): | 0.034 |
| Drug-inuced Liver Injury (DILI): | 0.297 | AMES Toxicity: | 0.034 |
| Rat Oral Acute Toxicity: | 0.516 | Maximum Recommended Daily Dose: | 0.292 |
| Skin Sensitization: | 0.015 | Carcinogencity: | 0.028 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.006 |
| Respiratory Toxicity: | 0.938 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC001922 | ![]() |
0.815 | D06CWH | ![]() |
0.269 | ||
| ENC004444 | ![]() |
0.800 | D0E9KA | ![]() |
0.266 | ||
| ENC005441 | ![]() |
0.798 | D01TSI | ![]() |
0.261 | ||
| ENC005440 | ![]() |
0.737 | D0V3ZA | ![]() |
0.254 | ||
| ENC005439 | ![]() |
0.735 | D0SP3D | ![]() |
0.254 | ||
| ENC005442 | ![]() |
0.703 | D0TB8C | ![]() |
0.248 | ||
| ENC004468 | ![]() |
0.664 | D0D7KC | ![]() |
0.248 | ||
| ENC004026 | ![]() |
0.653 | D09NNH | ![]() |
0.247 | ||
| ENC004541 | ![]() |
0.650 | D0W7RJ | ![]() |
0.246 | ||
| ENC002261 | ![]() |
0.639 | D0R1BD | ![]() |
0.246 | ||